FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

778527009: Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3738631013 Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5456434015 Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5456435019 Bismuth subcitrate potassium and metronidazole and tetracycline only product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) Has manufactured dose form Oral dose form true Inferred relationship Some
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Metronidazole (substance) true Inferred relationship Some 1
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) Count of base of active ingredient trois false Inferred relationship Some
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Tetracycline (substance) true Inferred relationship Some 2
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) Is a Product containing bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) true Inferred relationship Some
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) Is a Product containing only bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) true Inferred relationship Some
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. biskalcitrate de bismuth false Inferred relationship Some 3
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) Plays role Antibacterial therapeutic role (role) false Inferred relationship Some
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bismuth subcitrate potassium (substance) true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule Is a False Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) Inferred relationship Some
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) Is a True Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) Inferred relationship Some

This concept is not in any reference sets

Back to Start